DK0655063T3 - Ethynyl-alanin-aminodiolforbindelser med piperazinyl-endegruppe eller piperazinylamino-endegruppe til behandling af hyperte - Google Patents
Ethynyl-alanin-aminodiolforbindelser med piperazinyl-endegruppe eller piperazinylamino-endegruppe til behandling af hyperteInfo
- Publication number
- DK0655063T3 DK0655063T3 DK93919920T DK93919920T DK0655063T3 DK 0655063 T3 DK0655063 T3 DK 0655063T3 DK 93919920 T DK93919920 T DK 93919920T DK 93919920 T DK93919920 T DK 93919920T DK 0655063 T3 DK0655063 T3 DK 0655063T3
- Authority
- DK
- Denmark
- Prior art keywords
- piperazinyl
- end group
- group
- treatment
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Peptides Or Proteins (AREA)
- Cephalosporin Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/930,065 US5298505A (en) | 1992-08-14 | 1992-08-14 | Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
| PCT/US1993/007427 WO1994004536A1 (en) | 1992-08-14 | 1993-08-10 | Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0655063T3 true DK0655063T3 (da) | 1999-12-20 |
Family
ID=25458877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93919920T DK0655063T3 (da) | 1992-08-14 | 1993-08-10 | Ethynyl-alanin-aminodiolforbindelser med piperazinyl-endegruppe eller piperazinylamino-endegruppe til behandling af hyperte |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5298505A (da) |
| EP (1) | EP0655063B1 (da) |
| JP (1) | JPH08500115A (da) |
| AT (1) | ATE184876T1 (da) |
| AU (1) | AU682319B2 (da) |
| CA (1) | CA2138521A1 (da) |
| DE (1) | DE69326555T2 (da) |
| DK (1) | DK0655063T3 (da) |
| ES (1) | ES2136667T3 (da) |
| GR (1) | GR3031861T3 (da) |
| WO (1) | WO1994004536A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5508466A (en) * | 1994-04-13 | 1996-04-16 | G.D. Searle & Co. | Synthesis of N-protected-α-substituted-glycine racemic esters by zinc-mediated addition of organic halide to glycine cation equivalent |
| CA2467476A1 (en) * | 2001-11-19 | 2003-05-30 | Pharmacia & Upjohn Company | Amino diols useful in the treatment of alzheimer's disease |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59227851A (ja) * | 1983-06-09 | 1984-12-21 | Sankyo Co Ltd | レニン阻害作用を有するペプチド類 |
| EP0181110A3 (en) * | 1984-10-22 | 1988-05-11 | Kissei Pharmaceutical Co. Ltd. | Histidine derivatives as renin inhibitors |
| SU1676454A3 (ru) * | 1984-11-30 | 1991-09-07 | Санкио Компани Лимитед (Фирма) | Способ получени пептидов или их фармацевтически приемлемых солей |
| DK34086A (da) * | 1985-01-23 | 1986-07-24 | Abbott Lab | Peptidylaminodioler |
| JPS61236770A (ja) * | 1985-04-15 | 1986-10-22 | Kissei Pharmaceut Co Ltd | 新規なアミノ酸誘導体 |
| JPS6256458A (ja) * | 1985-09-04 | 1987-03-12 | Kissei Pharmaceut Co Ltd | 新規なアミノ酸誘導体 |
| EP0258289A4 (en) * | 1986-01-16 | 1991-01-02 | Joseph Dellaria | Peptide analogs |
| IL81234A (en) * | 1986-01-16 | 1992-09-06 | Abbott Lab | Peptidylaminodiols,process for their preparation and pharmaceutical compositions comprising them |
| US5032577A (en) * | 1986-12-31 | 1991-07-16 | Abbott Laboratories | Peptidylaminodiols |
| US4921855A (en) * | 1987-06-22 | 1990-05-01 | Fujisawa Pharmaceutical Co., Ltd. | New Histidyl amino acid derivatives, and pharmaceutical composition comprising the same |
| US5036053A (en) * | 1988-05-27 | 1991-07-30 | Warner-Lambert Company | Diol-containing renin inhibitors |
| US4902706A (en) * | 1988-07-01 | 1990-02-20 | G. D. Searle & Co. | Aminoalkylaminocarbonyl aminodiol amino acid derivatives as antihypertensive agents |
| IE902446A1 (en) * | 1989-07-26 | 1991-02-13 | Abbott Lab | Peptidyl aminodiol renin inhibitors |
| IE68045B1 (en) * | 1990-05-11 | 1996-05-15 | Abbott Lab | Renin inhibitors |
| US5227401A (en) * | 1991-10-29 | 1993-07-13 | G. D. Searle & Co. | Ethynyl alanine amino diol compounds for treatment of hypertension |
| US5223535A (en) * | 1991-10-29 | 1993-06-29 | G. D. Searle & Co. | Propargyl glycine amino propargyl diol compounds for treatment of hypertension |
| EP0539976A1 (en) * | 1991-10-29 | 1993-05-05 | G.D. Searle & Co. | Ethynyl-alanine-amino-diol compounds for treatment of hypertension |
-
1992
- 1992-08-14 US US07/930,065 patent/US5298505A/en not_active Expired - Fee Related
-
1993
- 1993-08-10 AT AT93919920T patent/ATE184876T1/de not_active IP Right Cessation
- 1993-08-10 ES ES93919920T patent/ES2136667T3/es not_active Expired - Lifetime
- 1993-08-10 WO PCT/US1993/007427 patent/WO1994004536A1/en active IP Right Grant
- 1993-08-10 DK DK93919920T patent/DK0655063T3/da active
- 1993-08-10 DE DE69326555T patent/DE69326555T2/de not_active Expired - Fee Related
- 1993-08-10 EP EP93919920A patent/EP0655063B1/en not_active Expired - Lifetime
- 1993-08-10 JP JP6506331A patent/JPH08500115A/ja active Pending
- 1993-08-10 CA CA002138521A patent/CA2138521A1/en not_active Abandoned
- 1993-08-10 AU AU49993/93A patent/AU682319B2/en not_active Ceased
-
1999
- 1999-11-17 GR GR990402955T patent/GR3031861T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69326555D1 (de) | 1999-10-28 |
| US5298505A (en) | 1994-03-29 |
| AU682319B2 (en) | 1997-10-02 |
| DE69326555T2 (de) | 2000-02-10 |
| EP0655063A1 (en) | 1995-05-31 |
| AU4999393A (en) | 1994-03-15 |
| ATE184876T1 (de) | 1999-10-15 |
| JPH08500115A (ja) | 1996-01-09 |
| EP0655063B1 (en) | 1999-09-22 |
| GR3031861T3 (en) | 2000-02-29 |
| WO1994004536A1 (en) | 1994-03-03 |
| CA2138521A1 (en) | 1994-03-03 |
| ES2136667T3 (es) | 1999-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2189968T3 (es) | Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS. | |
| DK0948527T3 (da) | Cylosporinderivater, fremstilling af disse og farmaceutiske præparater indeholdende disse | |
| HUP0003731A2 (hu) | 4-Bróm- vagy 4-jód-fenil-amino-benzhidroxámsav-származékok és ilyen vegyületek MEK gátlóként való alkalmazása | |
| DE69720773D1 (de) | SAUERSTOFF ODER SCHWEFEL ENTHALTENDE 5-GLIEDRIGE HETEROAROMATISHE DERIVATIVE ALS FACTOR Xa HEMMER | |
| NO970512L (no) | Nye heteroaryl-oksazolidinoner | |
| DK0655056T3 (da) | N-(Dihydroxyalkyl) -ethynylalanin-amider med azacyclyl-endegruppe til behandling af hypertension | |
| DK0759027T3 (da) | Bicykliske amidinderivater som inhibitorer af nitrogenoxidsynthetase | |
| DE69314497D1 (de) | Alkylamino-ethynyl-alanine-aminodiolverbindungen mit morpholino/thiomorpholinoendgruppen als renin inhibitoren | |
| DK0888379T3 (da) | Forbindelser tilhørende amidinium-familien, farmaceutiske præparater indeholdende disse forbindelser og anvendelsen deraf | |
| DK0655063T3 (da) | Ethynyl-alanin-aminodiolforbindelser med piperazinyl-endegruppe eller piperazinylamino-endegruppe til behandling af hyperte | |
| DK0655059T3 (da) | Imidazolyl/benzimidazolyl-terminerede alkylaminoethynylalaninaminodiol-forbindelser til behandling af hypertension | |
| DK0655058T3 (da) | Pyridinyl/quinolinyl-terminerede alkylamino-ethynyl-alanin-aminodiol-forbindelser til behandling af hypertension | |
| DK0904270T3 (da) | Dihydrobenzofuran og beslægtede forbindelser anvendelige som antiinflammatoriske midler | |
| HUP0303137A2 (hu) | Kettős hatású antioxidáns és antiaritmiás szerek | |
| ES2052535T3 (es) | Sintesis de amino-alquil-amidas de peptidos o hidrazidas de peptidos mediante un metodo en fase solida. | |
| DK0475413T3 (da) | Carbocycliske nukleosidanaloge, der kan anvendes som immunsuppressorer | |
| DE3650564D1 (de) | Dipeptide-Analoge von Aspertam und Verfahren zur deren Herstellung, sowie eine neue Herstellung von Aspertam | |
| DK0716658T3 (da) | Glycosylamider af 2-aminocylamino-2-desoxysukkerarter | |
| DK1098901T3 (da) | Nye 6-deoxyerythromycinderivater, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler | |
| DE3781691D1 (de) | Tetrapeptid-hemmstoff zum eintritt in den kreislauf von hemopoietischen stammzellen, verfahren zu deren herstellung und deren anwendungen. | |
| TH43749A (th) | อนุพันธ์เบนโซซาซีน การเตรียมและการใช้มันเพื่อการบำบัดรักษาโรค |